Companies

TG THERAPEUTICS, INC. (TGTX) SEC filings

CIK 0001001316 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2013FY2012
Revenue (USD)616.3 M2.8 M
Net income (USD)-20.5 M-853074
Diluted EPS (USD/shares)2.77-1.65

Latest filings

FiledFormDescriptionPeriod
2026-09-144FORM 42026-09-10
2026-09-10144144
2026-08-074FORM 42026-08-06
2026-08-0510-QFORM 10-Q2026-06-30
2026-08-038-KFORM 8-K items 2.02,9.012026-08-03
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-154FORM 42026-06-11
2026-06-128-KFORM 8-K items 5.072026-06-11
2026-06-038-KFORM 8-K items 8.01,9.012026-06-03
2026-05-278-KFORM 8-K items 8.01,9.012026-05-27
2026-05-0610-QFORM 10-Q2026-03-31
2026-05-068-KFORM 8-K items 2.02,9.012026-05-06
2026-04-30DEF 14AFORM DEF 14A2026-06-11
2026-04-29SCHEDULE 13GSCHEDULE 13G
2026-03-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-208-KFORM 8-K items 1.01,2.03,9.012026-03-18
2026-02-2710-KFORM 10-K2025-12-31
2026-02-268-KFORM 8-K items 2.02,9.012026-02-26
2026-01-294FORM 42026-01-28
2026-01-138-KFORM 8-K items 7.01,9.012026-01-13
2026-01-094FORM 42026-01-08
2026-01-094FORM 42026-01-08

Forms on file (last 1,000): 4 293, 8-K 229, 10-Q 59, SC 13G/A 52, 3 25, SC 13G 24, 424B3 23, DEF 14A 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TGTX (0.002 USD), /gw/filings/filings?ticker=TGTX&form=8-K, /gw/filings/facts?ticker=TGTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange